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Abstract
Background: Based on the proven efficacy of lactate in predicting mortality and morbidity in sepsis when
measured early in the resuscitative protocol, our group hypothesized that this utility extends later in the course of
care. This study sought to investigate the prognostic potential of plasma lactate clearance measured 24–48 h after
the initiation of treatment for nonsurgical patients with sepsis, severe sepsis, and septic shock.
Methods: Plasma lactate values, measured 24–48 h after the initiation of treatment, were collected in nonsurgical
septic, severe septic, and septic shock patients. The primary outcome was 30-day mortality, while secondary
outcomes included requirements for vasopressors and boluses of intravenous fluids. Analysis of these three
outcomes was performed while controlling for clinical severity as measured by Sequential Organ Failure Assessment
(SOFA), renal dysfunction, and hepatic dysfunction. Lactate clearance was defined as the percent change in plasma
lactate levels measured after 24–48 h of treatment from the plasma lactate level at initial presentation.
Results: Two hundred twenty-nine nonsurgical patients were divided into two groups, clearers (above median
lactate clearance [31.6 %]) and nonclearers (below median lactate clearance [31.6 %]). The adjusted odds ratio of
mortality in clearers compared to nonclearers was 0.39 (CI 0.20–0.76) (p = 0.006). For vasopressor requirement, the
adjusted odds ratio was 0.41 (CI 0.21–0.79) in clearers compared to nonclearers (p = 0.008). For intravenous fluid
bolus requirement, the adjusted odds ratio was 0.81 (CI 0.48–1.39) in clearers compared to nonclearers (p = 0.45).
Conclusions: Lower plasma lactate clearance 24–48 h after the initiation of treatment is associated with higher 30-
day mortality and requirements for vasopressors in nonsurgical septic patients and may be a useful noninvasive
measurement for guiding late-sepsis treatment. Further investigation looking at mechanisms and therapeutic
targets to improve lactate clearance in late sepsis may improve patient mortality and outcomes.
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Background
The rate of sepsis-related intensive care unit (ICU) admis-
sions has increased steadily over the last decade, with hos-
pitalizations for sepsis doubling and close to one million
Americans affected annually [1–3]. Nearly a decade since
the landmark article, “Surviving Sepsis Campaign Guide-
lines for Management of Severe Sepsis and Septic Shock”,
sepsis remains a hotbed of research, and new diagnostic
and resuscitative interventions are continually under de-
velopment and evaluation. One such effort that has re-
ceived focus is the role of lactate monitoring [1, 3–5].
In their 2004 and 2008 sepsis guidelines, Dellinger
et al. recommended measurement of lactate on initial
presentation [1, 6–8]. In addition, many clinicians and
researchers have attempted to capitalize on the test’s
theoretical diagnostic and predictive value by including
additional measurements during the resuscitation
process [2, 9–12]. For example, it was shown that lactate
clearance greater than 10 % from initial measurement
during the first 2 to 6 h of resuscitation predicted sur-
vival from septic shock and that protocols targeting
lactate clearance of at least 10 % produced similar short-
term survival rates to protocols using central venous
oxygen saturation (ScVO2) monitoring [2, 3, 9, 11].
In addition to lactate clearance’s utility early in the resus-
citation process, there have been some investigations of lac-
tate’s predictive value at later time periods [13–17]. In a
137 Surgical Intensive Care Unit (SICU)-patient study,
Husain et al. showed elevated initial and 24-h lactate levels
to be significant predictors of mortality, with mortality ran-
ging from 10 to 67 % depending on whether lactate levels
normalized or failed to normalize after 24 h, respectively
[18]. In another study investigating SICU patients, Bakker
et al. showed that lactate clearance measured 24 h after ad-
mission was a significant predictor of in-hospital death and
that the duration of lactic acidosis was more predictive of
mortality than the initial lactate value [13].
These reports suggest that lactate measurements more
than 24 h from the initiation of resuscitation have pre-
dictive and prognostic utility [19–21]. Motivated by
these reports and the lack of explicit guidelines in the
medical literature, we sought to investigate the utility
and prognostic potential of lactate clearance, measured
24–48 h after the onset of resuscitation. Specifically, our
aim was to determine whether lower lactate clearances,
measured 24–48 h after the onset of resuscitation, was
associated with increased 30-day mortality and require-
ments for boluses of intravenous fluids and vasopressors
in patients treated for sepsis.
Methods
Setting
The study was a single-center retrospective cohort study
of adult nonsurgical patients with admission diagnoses
of sepsis, severe sepsis, and/or septic shock, admitted to
UF-Health during 2013, and approved by the Institu-
tional Review Board (IRB) at the University of Florida
(UF) College of Medicine, Gainesville, Florida. The pa-
tients and their respective diagnoses of sepsis, severe sep-
sis, and/or septic shock were obtained through database
query using ICD coding and confirmed via chart review.
This same strategy allowed for exclusion of patients ad-
mitted for noninfectious SIRS. All patients were treated at
UF-Health, which is a 946-bed quaternary care institution.
All patients deemed critically ill were admitted to the UF-
Health MICU, which is a 24-bed unit staffed 24 h daily by
board-certified pulmonary-critical care physicians, internal
medicine residents, and nurses trained and/or board certi-
fied in critical care.
Inclusion and exclusion criteria
Adult patients admitted to UF-Health in Gainesville,
Florida, during 2013 with a diagnosis of sepsis, severe sep-
sis, and/or septic shock were retrospectively chart reviewed.
Inclusion criteria included patients with (a) one or more of
the aforementioned admission diagnoses in the appropriate
time period and (b) an initial lactate measurement followed
by one or more lactate measurements taken 24–48 h after
resuscitation efforts started. All of these patients had lactate
measurements on admission, but only the first lactate
measurement taken after 24–48 h was recorded and used
for analysis (Fig. 1).
Patient management
All patients were managed according to our institutional
sepsis guidelines including lactate measurement on ar-
rival, fluid resuscitation with evaluation of dynamic mea-
sures of fluid response with a goal to achieve a mean
arterial blood pressure (MAP) equal or greater than
65 mmHg, vasopressor medications whenever necessary
to achieve the goal MAP after fluid resuscitation, infec-
tion source control, cultures, and appropriate antibiotic
therapy [22]. For all patients, resuscitation efforts were
either initiated in the emergency room or on the medical
floor. The institutional resuscitation policy for sepsis is
identical regardless of the location of initiation (i.e.,
emergency room, floor). All patients received antibiotic
therapy with the initiation of treatment, and although
not recorded, the appropriateness of antibiotic therapy
did not differ between the two patient groups, which
was confirmed via chart review. Depending on respira-
tory status, patients were treated with oxygen therapy,
noninvasive positive pressure ventilation (NIPPV), or in-
tubation with mechanical ventilation.
Data collection
Patient’s gender, age, admission diagnoses, admission
lactate values, and lactate values measured after 24–48 h
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of resuscitation were recorded. Data collected for Se-
quential Organ Failure Assessment (SOFA) scores in-
cluded the worst values obtained within 24 h of
resuscitation for the following: PaO2, FiO2, platelet
count, Glascow Coma Score (GCS), total bilirubin, cre-
atinine, and either receipt of vasopressors or MAP.
Kidney function was recorded as the estimated glomeru-
lar filtration rate (EGFR), which was calculated using the
Modification of Diet in Renal Disease (MDRD) for-
mula. Liver dysfunction was recorded as the Model
for End-Stage Liver Disease (MELD) score, which was
calculated using the MELD model. Volume resuscita-
tion with boluses of intravenous fluid (yes/no) and
vasopressor therapies (yes/no) administered after 24 h
were collected as secondary outcomes.
Lactate clearance definition
The following formula was used to define lactate clear-
ance: Initial lactate measured at the start of treatment
minus lactate measured after 24–48 h, divided by initial
lactate (Lactate Clearance = LactateInitial − Lactateafter 24–
48 h/LactateInitial). A negative value represents an in-
crease in lactate, while a positive value represents a de-
crease in lactate.
Clearers vs. nonclearers
Since review of the literature does not clearly define a
significant lactate clearance threshold, the median clear-
ance was used to divide the patients into two groups
[clearers (patients > median) and nonclearers (patients <
median)]. The use of median clearance as a cutoff be-
tween clearers and nonclearers was validated using re-
ceiver operator curve analyses (Fig. 2). The optimal
value was found by linear discriminant analysis using
SOFA score as an independent predictor of mortality.
The optimal divisor was found to be close to the median
value lactate clearance (31.60 %) in the sample of all
patients.
Baseline similarity of clearers vs. nonclearers
The age, diagnosis, EGFR, and MELD score of the pa-
tient groups (clearers and nonclearers) were compared
to ensure similarity at baseline (Table 1).
Statistical analysis
The SAS (BASE) version 9.4 and also “R” software pro-
grams were used for data analysis. Thirty-day mortality
was calculated by dividing the number of deaths within
30 days of ICU admission by the total number of pa-
tients analyzed in the study. Statistical significance was
defined as p < 0.05. Estimates for 30-day mortality com-
parisons (clearers versus nonclearers) were calculated
using odds ratio. Association between clearance groups
and outcome was measured with chi-squared testing for
independence. In addition, secondary outcomes of intra-
venous fluid bolus and vasopressor receipt were com-
pared between clearers and nonclearers. Sensitivity
analysis for all outcomes was performed using multiple
Fig. 1 Shows the study flow diagram
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logistic regression analysis with additional covariates in
order to control for the effects of confounding related to
disease severity and comorbidities. Estimates for each
outcome effect, while controlling for SOFA score, EGFR,
and MELD, are included in the analysis. Wald tests and
95 % two-sided confidence intervals are presented. The
demographic variables of age, sex, and admission diagnosis
were analyzed between clearers and nonclearers using the
chi-squared test in order to investigate for homogeneity be-
tween groups (Table 1).
Results
Primary outcome: 30-day mortality
A total of 229 patients, 129 men and 100 women, admit-
ted during 2013 were analyzed (Table 1). With the diagno-
sis of sepsis, severe sepsis, and septic shock, respectively,
24.0, 17.5, and 58.5 % of the patients were admitted. Pa-
tients had a mean baseline SOFA score of 8.26 ± 4.15 and
a median lactate clearance of 31.6 % after a mean of 31 h
after admission. The 30-day mortality rate was 29.69 %.
Before controlling for SOFA, the odds of mortality in
clearers compared to nonclearers was 0.44 with 95 % con-
fidence interval (0.24–0.78). A chi-squared test for inde-
pendence revealed an association between level of
clearance and mortality rate (p = 0.005) (Table 2). Multiple
logistic regression modeling was then performed with lac-
tate clearance, EGFR, MELD, and SOFA score, with the
odds ratio and confidence interval being 0.39 (0.20–0.76)
(p = 0.006), respectively (Figs. 3 and 4).
Secondary outcomes: need for vasopressors and IVF
boluses
Vasopressor requirement
Vasopressor receipt was defined as receiving (yes/no) any
dose of dopamine, epinephrine, or norepinephrine 24 h
after the initiation of resuscitation efforts. The odds of
vasopressor receipt in clearers compared with nonclearers
was 0.46 with 95 % confidence interval (0.27–0.79). A test
for independence confirmed an association between level
of clearance and vasopressor requirement (p = 0.005)
(Table 2). After adjusting for SOFA score, MELD, and
EGFR, multiple logistic regression estimated the odds ra-
tio of requiring vasopressors was 0.41 with 95 % confi-
dence interval (0.21–0.79) (p = 0.008) (Figs. 5 and 6).
Fig. 2 Shows the ROC curve and comparison for the optimal
clearance divisor value (25.89 %) and the median clearance value
(31.60 %). The figure shows that the two values (25.89 %; 31.60 %)
have roughly the same area under the curve (not significantly
different using linear discriminant analysis). Since the two values
(25.89 and 31.60 %) perform similarly, we were confident in our
ability to use the median clearance value, 31.60 %, as our cutoff to
divide the two groups of patients (clearers and nonclearers)
Table 1 Patient demographics
Clearers Nonclearers p (alpha level 0.05)
Age (Avg. years) 60.2 61.3 p = 0.250
Sex 61.90 % M/38.1 % F 53.33 % M/46.67 % F p = 0.212
Initial lactate 4.08 2.51 p = 0.010
Lactate clearance time (s) 32.0 (SD = 4.93) 31.3 (SD = 4.96) p = 0.782
Diagnosis
Sepsis 56.36 % 43.64 % p = 0.307
Severe sepsis 55.00 % 45.00 % p = 0.324
Septic shock 45.52 % 54.48 % p = 0.321
Organ function
Kidney function (EGFR) 47.4 45.9 p = 0.531
Liver function (MELD) 15.6 16.6 p = 0.363
Total (N) 115 114
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Intravenous fluid (IVF) bolus requirement
The need for intravenous fluid bolus resuscitation was
defined as the receipt of intravenous fluids, including
normal saline or lactated ringers administered as a bolus
dose of 250 cm3 or more, 24 h after the initiation of
treatment. The odds of receiving IVF boluses in clearers
compared with nonclearers was 0.72 with 95 % confi-
dence interval (0.43–1.22). A test for independence be-
tween clearers and nonclearers concluded there was no
association with IVF receipt (p = 0.22) (Table 2). Sensi-
tivity analysis with multiple logistic regression estimated
for the SOFA, EGFR, and MELD adjusted odds ratio of
IVF in clearers vs. nonclearers was 0.81 with 95 % confi-
dence interval (0.48–1.39) (p = 0.45) (Figs. 7 and 8).
Discussion
The prognostic potential of plasma lactate and lactate clear-
ance in the management of early sepsis has been repeatedly
validated in the critical care literature [2, 9–12, 23–25]. The
majority of these investigations have focused on lactate
clearance within the initial 6 h of resuscitation, while stud-
ies investigating lactate’s utility later in resuscitation consist
mostly of small patient populations in surgical and trauma
settings [13–17].
Our first finding reveals that nonclearers of lactate
(below the median level of lactate clearance) had a
higher 30-day mortality rate than clearers. These find-
ings coincide with a 94-patient SICU sepsis study, where
Marty et al. measured lactate at time0 (T), T6, T12, and
T24 and showed that the best predictor of death was the
T24 clearance [26]. Similarly, in an 81-patient study,
Herwanto et al. investigated the role of 6-, 12-, and 24-h
lactate clearance in patients with sepsis and septic shock
and showed only the 24-h lactate clearance measure-
ments to be associated with mortality [27].
Regarding vasopressor requirements, we found that
patients with lower lactate clearance had a significantly
higher requirement for vasopressors than patients with
higher lactate clearance after 24 h of sepsis treatment.
Vasopressors are used in septic shock to restore and
Table 2 Primary and secondary outcomes
Analysis group Odds ratio 95 % confidence interval p (alpha level 0.05)
Mortality
(i) Clearers/nonclearers Unadjusted OR 0.44 (0.24–0.78) 0.005
(ii) Clearers/nonclearers OR adjusted for SOFA 0.45 (0.24–0.85) 0.014
(iii) Clearers/nonclearers OR adjusted SOFA, EGFR, and MELD 0.39 (0.20–0.76) 0.006
Receipt of IV fluids
(i) Clearers/nonclearers Unadjusted OR 0.72 (0.43–1.22) 0.22
(ii) Clearers/nonclearers OR adjusted for SOFA 0.74 (0.44–1.26) 0.27
(iii) Clearers/Nonclearers OR adjusted SOFA, EGFR, and MELD 0.81 (0.48–1.39) 0.45
Receipt of vasopressors
(i) Clearers/nonclearers Unadjusted OR 0.46 (0.27–0.79) 0.005
(ii) Clearers/nonclearers OR adjusted for SOFA 0.43 (0.23–0.83) 0.012
(iii) Clearers/nonclearers OR adjusted SOFA, EGFR, and MELD 0.41 (0.21–0.79) 0.008
Fig. 3 Shows a statistically significant association between mortality
and lactate clearance adjusted for SOFA, EGFR, and MELD
Fig. 4 Shows the primary outcome, mortality, with statistically significant
differences between the two groups (clearers and nonclearers)
Chertoff et al. Journal of Intensive Care  (2016) 4:13 Page 5 of 8
maintain appropriate perfusion pressures to avoid end-
organ damage. In our population, clearers after 24–48 h
required vasopressors less frequently than nonclearers as
their lactate improved. On the contrary, despite contin-
ued use of vasopressors to keep adequate perfusion pres-
sures, the low clearance group was unable to improve
their lactate levels, while having higher mortality. Thus,
in managing patients in late sepsis, restoring adequate
perfusion pressure with vasopressors might not be suffi-
cient to reverse all of the causes of hyperlactemia.
Our final finding reveals no significant difference in
the requirement for intravenous fluid boluses between
the clearers and nonclearers. We believe that this finding
is consistent with current treatment approaches calling
initially for aggressive fluid resuscitation, followed by
vasopressor use only after fluid resuscitation has been
established.
New insights into the mechanism for hyperlactemia in
sepsis certainly call into question the traditional thinking
that hyperlactemia in sepsis and septic shock is only a
result of underresuscitation that should be followed im-
mediately with aggressive systemic resuscitation. Instead,
the current thinking suggests that after initial resuscita-
tion, the focus should shift more towards infection
control and supportive care and less on systemic resusci-
tation [28–36]. For example, Otto et al. showed that the
later phases of sepsis are associated with a significant re-
increase in positive blood culture results, especially
opportunistic bacteria and fungi [36]. Despite this mech-
anistic uncertainty, many experts in the field of sepsis
continue to support the use of lactate as a marker of
early-sepsis recovery [37–39]. However, the role of lac-
tate clearance after initial resuscitation and in late-sepsis
management and its potential to guide treatment at
these later stages remains unclear [33].
There are inherent limitations in our study worth
mentioning. First, our study of 229 patients is limited in
size, but this remains larger than any previous studies
looking at lactate measurements of septic patients at this
Fig. 5 Shows a statistically significant association between vasopressor
receipt and lactate clearance adjusted for SOFA, EGFR, and MELD
Fig. 6 Shows statistically significant differences in vasopressor
receipt between the two groups (clearers and nonclearers)
Fig. 7 Does not show a statistically significant association between
intravenous fluid bolus receipt and lactate clearance adjusted for
SOFA, EGFR, and MELD
Fig. 8 Does not show statistically significant differences in intravenous
fluid bolus receipt between the two groups (clearers and nonclearers)
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specific time period. Consequently, Figs. 3 and 5 show
an indirect relationship between SOFA and mortality for
clearers at the greatest SOFA values. This anomalous
finding can be explained by chance and randomness sec-
ondary to few clearers having such high SOFA values.
Another potential limitation lies in our study being con-
ducted at a single institution, since variations in treat-
ment protocols among institutions might potentially
yield different relationships between lactate and out-
comes. Next, there was a statistically significant differ-
ence between the clearers and nonclearers with respect
to initial lactate values. In fact, we found the clearers to
have a higher initial lactate than the nonclearers, which
implies that the clearers may have had more severe sep-
sis (higher initial lactate) on presentation than the non-
clearers (lower initial lactate). In prior studies, it has
been shown that the initial lactate is directly associated
with mortality, but our findings show an indirect associ-
ation [1–3]. Thus, despite having more severe sepsis, the
clearers had less mortality than the nonclearers. This in-
teresting finding can be attributed to the fact that the
clearers had a higher late-lactate clearance than the non-
clearers. Finally, our results were for nonsurgical patients
making extrapolations to surgical patients potentially
inaccurate.
There is little debate that early identification and man-
agement of septic patients improves outcomes [3, 6, 7].
Our study’s intent was to investigate patients after the ini-
tial phase of sepsis treatment to better understand and de-
fine late-sepsis patients. The findings in our study shed
light on late-sepsis management by looking at late-lactate
clearance as a marker to monitor recovery. This study not
only illustrates the potential role of lactate clearance as a
surrogate for late-sepsis recovery but also suggests that
new management strategies should be evaluated for septic
patients with a low lactate clearance [40, 41].
Conclusions
Our study aimed to elucidate whether the utility of lactate
clearance early in the resuscitation of septic patients ex-
tended further into the course of their care. Our results re-
vealed statistically significant associations between lactate
clearance, measured 24–48 h after the initiation of treat-
ment, mortality, and the requirement for vasopressors. Fur-
ther investigations aimed at early recognition, as well as
novel and alternative interventions directed at patients with
low lactate clearance after 24–48 h of resuscitation, may re-
duce sepsis mortality and improve overall outcomes.
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